Skip to content Skip to footer
Subscribe Now
Insights+ Key Biosimilars Events of May 2022
INSIGHTS+
Insights+ Key Biosimilars Events of May 2022
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potencyBiosimilars are expected to be a cost-effective alternative to the high-priced branded biologics, offering significant and much-needed cost savings to both payers and the patientsDuring the month of May, JSR Life Sciences launches Similis Bio business…
June 2, 20220Comments
PharmaShots Interview In Conversation with Amolyt’s CEO, Thierry Abribat, Where he Shares Insights on Amolyt as a Key Player in Hypoparathyroidism Space
VIEWPOINTS
PharmaShots Interview: In Conversation with Amolyt’s CEO, Thierry Abribat, Where he Shares Insights on Amolyt as a Key Player in Hypoparathyroidism Space
Shots:Thierry spoke about the IND clearance of its lead candidate in hypoparathyroidism and the company’s clinical trial plans for rare endocrine and related diseasesThierry also communicated about the closing of funding Series B equity financing roundThe interview gives a deeper understanding of Hypoparathyroidism and its treatment optionsSmriti: What did this Investigational…
June 1, 20220Comments
PharmaShots Interview In Conversation with Pyxis’ CMO Jay M. Feingold, Where he Shares Insights on the addition of In-Licensed & Internal IO Assets
VIEWPOINTS
PharmaShots Interview: In Conversation with Pyxis’ CMO Jay M. Feingold, Where he Shares Insights on the addition of In-Licensed & Internal IO Assets
Shots:Jay talked about the in-licensing of an IND-ready immuno-oncology (IO) candidate, anti-Siglec-15 Mab to the pipelineJay also spoke about the company’s IO targets and other under development immunotherapiesIn addition, the interview provided the corporate and financial updates of the Pyxis OncologySmriti: Can you tell us something about your in-licensed Mab anti-Siglec-15,…
May 31, 20220Comments
PharmaShots Interview MindMed’s Robert Barrow Shares Insights on Study to show Key Differences Between LSD and Psilocybin
VIEWPOINTS
PharmaShots Interview: MindMed’s Robert Barrow Shares Insights on Study to show Key Differences Between LSD and Psilocybin
In an interview with PharmaShots, Robert Barrow, CEO at MindMed shared his views on the Study Acute Effects of Lysergic Acid Diethylamide vs. Psilocybin in Healthy SubjectsShots:Robert spoke about the data from the peer-reviewed publication of a study comparing the acute effects of LSD and psilocybin in healthy subjectsRobert also emphasized the clinical results and significance of…
May 30, 20220Comments
PharmaShots Interview Medicago’s Brian Ward Shares Insights on COVIFENZ, a Plant-Based COVID-19 Vaccine
VIEWPOINTS
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on COVIFENZ, a Plant-Based COVID-19 Vaccine
In an interview with PharmaShots, Brian Ward, CEO at Medicago shared his views on the approval of a Plant-Based COVID-19 Vaccine in combination with GSK’s pandemic adjuvantShots:Brian talked about the data that supported the approval of Medicago’s plant-based Covid-19 vaccine by Health CanadaHe focused on the safety and efficacy of the vaccine…
May 25, 20220Comments
13th Summit on Biosimilars & Innovator Biologics
EVENTS
13th Summit on Biosimilars & Innovator Biologics
The American Conference Institute invites you to attend the 13th Summit on Biosimilars & Innovator Biologics on June 28-29, 2022, back in-person in Boston! Gain government and industry insights on the Innovator and Biosimilars Marketplace from the U.S. FTC, USPTO, AAM, BIO and leading In-House Counsel.We’ve reached an inflection point in the United States. With another major wave of loss…
May 23, 20220Comments